{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:16:18Z","timestamp":1784855778633,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 CA239588-01"],"award-info":[{"award-number":["1R01 CA239588-01"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T cell responses to Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) are likely essential in the control of KSHV infection and protection from associated disease, but remain poorly characterised. KSHV prevalence in rural Uganda is high at &gt;90%. Here we investigate IFN- \u03b3 T cell responses to the KSHV proteome in HIV-negative individuals from a rural Ugandan population. We use an ex-vivo IFN- \u03b3 ELISpot assay with overlapping peptide pools spanning 83 KSHV open reading frames (ORF) on peripheral blood mononuclear cells (PBMC) from 116 individuals. KSHV-specific T cell IFN- \u03b3 responses are of low intensity and heterogeneous, with no evidence of immune dominance; by contrast, IFN- \u03b3 responses to Epstein\u2013Barr virus, Cytomegalovirus and influenza peptides are frequent and intense. Individuals with KSHV DNA in PBMC have higher IFN- \u03b3 responses to ORF73 (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) and lower responses to K8.1 (<jats:italic>p<\/jats:italic>\u2009=\u20090.004) when compared with those without KSHV DNA. In summary, we demonstrate low intensity, heterogeneous T cell responses to KSHV in immune-competent individuals.<\/jats:p>","DOI":"10.1038\/s41467-021-27623-8","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:07:13Z","timestamp":1639652833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Kaposi\u2019s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-4735","authenticated-orcid":false,"given":"Angela","family":"Nalwoga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-3141","authenticated-orcid":false,"given":"Romin","family":"Roshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-241X","authenticated-orcid":false,"given":"Kyle","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell","family":"Miley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazzarena","family":"Labo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Nakibuule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-9153","authenticated-orcid":false,"given":"Robert","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-2563","authenticated-orcid":false,"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"27623_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.semcancer.2008.10.005","volume":"18","author":"AD Hislop","year":"2008","unstructured":"Hislop, A. D. & Sabbah, S. CD8+ T cell immunity to Epstein-Barr virus and Kaposi\u2019s sarcoma-associated herpes virus. Semin Cancer Biol. 18, 416\u2013422 (2008).","journal-title":"Semin Cancer Biol."},{"key":"27623_CR2","doi-asserted-by":"publisher","first-page":"340356","DOI":"10.1155\/2010\/340356","volume":"2010","author":"RC Robey","year":"2010","unstructured":"Robey, R. C., Mletzko, S. & Gotch, F. M. The T-cell immune response against Kaposi\u2019s sarcoma-associated herpesvirus. Adv. Virol. 2010, 340356 (2010).","journal-title":"Adv. Virol."},{"key":"27623_CR3","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/QAD.0000000000001567","volume":"31","author":"PH Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves, P. H., Uldrick, T. S. & Yarchoan, R. HIV-associated Kaposi sarcoma and related diseases. Aids 31, 1903\u20131916 (2017).","journal-title":"Aids"},{"key":"27623_CR4","doi-asserted-by":"crossref","unstructured":"Lagos, D. & Boshoff, C. Immunobiology and host response to KSHV infection. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (eds Arvin, A. et al.) (Cambridge University Press Copyright \u00a9 Cambridge University Press, Cambridge, 2007).","DOI":"10.1017\/CBO9780511545313.053"},{"key":"27623_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/TP.0b013e318184112c","volume":"86","author":"P Barozzi","year":"2008","unstructured":"Barozzi, P. et al. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 86, 738\u2013744 (2008).","journal-title":"Transplantation"},{"key":"27623_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semarthrit.2008.05.005","volume":"39","author":"P Barozzi","year":"2009","unstructured":"Barozzi, P. et al. Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi\u2019s sarcoma in a patient with undifferentiated arthritis. Semin. Arthritis Rheum. 39, 170\u2013175 (2009).","journal-title":"Semin. Arthritis Rheum."},{"key":"27623_CR7","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/QAD.0b013e3283300a91","volume":"23","author":"F Bihl","year":"2009","unstructured":"Bihl, F. et al. Cellular immune responses and disease control in acute AIDS-associated Kaposi\u2019s sarcoma. Aids 23, 1918\u20131922 (2009).","journal-title":"Aids"},{"key":"27623_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/507648","volume":"194","author":"A Guihot","year":"2006","unstructured":"Guihot, A. et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J. Infect. Dis. 194, 1078\u20131088 (2006).","journal-title":"J. Infect. Dis."},{"key":"27623_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","volume":"18","author":"D Bourboulia","year":"2004","unstructured":"Bourboulia, D. et al. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. Aids 18, 485\u2013493 (2004).","journal-title":"Aids"},{"key":"27623_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1056\/NEJMc070508","volume":"357","author":"T Maurer","year":"2007","unstructured":"Maurer, T., Ponte, M. & Leslie, K. HIV-associated Kaposi\u2019s sarcoma with a high CD4 count and a low viral load. N. Engl. J. Med. 357, 1352\u20131353 (2007).","journal-title":"N. Engl. J. Med."},{"key":"27623_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.coviro.2013.04.004","volume":"3","author":"WJ Ouwendijk","year":"2013","unstructured":"Ouwendijk, W. J. et al. T-cell immunity to human alphaherpesviruses. Curr. Opin. Virol. 3, 452\u2013460 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"27623_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12703\/P6-28","volume":"6","author":"N Terrazzini","year":"2014","unstructured":"Terrazzini, N. & Kern, F. Cell-mediated immunity to human CMV infection: a brief overview. F1000Prime Rep. 6, 28 (2014).","journal-title":"F1000Prime Rep."},{"key":"27623_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2567.2002.01424.x","volume":"106","author":"F Micheletti","year":"2002","unstructured":"Micheletti, F. et al. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 106, 395\u2013403 (2002).","journal-title":"Immunology"},{"key":"27623_CR14","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1128\/JVI.73.7.6136-6140.1999","volume":"73","author":"M Osman","year":"1999","unstructured":"Osman, M. et al. Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J. Virol. 73, 6136\u20136140 (1999).","journal-title":"J. Virol."},{"key":"27623_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7196\/SAMJ.2019.v109i8b.13825","volume":"109","author":"J Mellet","year":"2019","unstructured":"Mellet, J. et al. Human leukocyte antigen (HLA) diversity and clinical applications in South Africa. S Afr. Med J. 109, 29\u201334 (2019).","journal-title":"S Afr. Med J."},{"key":"27623_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","volume":"21","author":"F Bihl","year":"2007","unstructured":"Bihl, F. et al. Kaposi\u2019s sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposi\u2019s sarcoma. Aids 21, 1245\u20131252 (2007).","journal-title":"Aids"},{"key":"27623_CR17","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2011-07-366476","volume":"119","author":"S Sabbah","year":"2012","unstructured":"Sabbah, S. et al. T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells. Blood 119, 2083\u20132092 (2012).","journal-title":"Blood"},{"key":"27623_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-981-10-7230-7_14","volume":"1045","author":"K Ueda","year":"2018","unstructured":"Ueda, K. KSHV genome replication and maintenance in latency. Adv. Exp. Med. Biol. 1045, 299\u2013320 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"27623_CR19","doi-asserted-by":"publisher","first-page":"e1004046","DOI":"10.1371\/journal.ppat.1004046","volume":"10","author":"N Labo","year":"2014","unstructured":"Labo, N. et al. Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. PLoS Pathog. 10, e1004046 (2014).","journal-title":"PLoS Pathog."},{"key":"27623_CR20","doi-asserted-by":"publisher","first-page":"109402","DOI":"10.18632\/oncotarget.22683","volume":"8","author":"R Roshan","year":"2017","unstructured":"Roshan, R. et al. T-cell responses to KSHV infection: a systematic approach. Oncotarget 8, 109402\u2013109416 (2017).","journal-title":"Oncotarget"},{"key":"27623_CR21","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","volume":"17","author":"EA Engels","year":"2003","unstructured":"Engels, E. A. et al. Detection and quantification of Kaposi\u2019s sarcoma-associated herpesvirus to predict AIDS-associated Kaposi\u2019s sarcoma. Aids 17, 1847\u20131851 (2003).","journal-title":"Aids"},{"key":"27623_CR22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/QAD.0b013e3282202b7d","volume":"21","author":"AS Laney","year":"2007","unstructured":"Laney, A. S. et al. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi\u2019s sarcoma. Aids 21, 1541\u20131545 (2007).","journal-title":"Aids"},{"key":"27623_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2007.12.025","volume":"263","author":"MM Nsubuga","year":"2008","unstructured":"Nsubuga, M. M. et al. Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett. 263, 182\u2013188 (2008).","journal-title":"Cancer Lett."},{"key":"27623_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/341088","volume":"186","author":"C Pellet","year":"2002","unstructured":"Pellet, C. et al. Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma. J. Infect. Dis. 186, 110\u2013113 (2002).","journal-title":"J. Infect. Dis."},{"key":"27623_CR25","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1128\/JCM.39.12.4269-4273.2001","volume":"39","author":"R Tedeschi","year":"2001","unstructured":"Tedeschi, R. et al. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi\u2019s sarcoma. J. Clin. Microbiol. 39, 4269\u20134273 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"27623_CR26","doi-asserted-by":"crossref","unstructured":"Nalwoga, A. et al. Risk factors for Kaposi\u2019s sarcoma associated herpesvirus (KSHV) DNA in blood and in saliva in rural Uganda. Clin. Infect. Dis. 71, 1055\u20131062 (2020).","DOI":"10.1093\/cid\/ciz916"},{"key":"27623_CR27","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/ijc.29329","volume":"136","author":"K Wakeham","year":"2015","unstructured":"Wakeham, K. et al. Trends in Kaposi\u2019s sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi\u2019s sarcoma: a nested case-control study. Int. J. Cancer 136, 2822\u20132830 (2015).","journal-title":"Int. J. Cancer"},{"key":"27623_CR28","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/j.1349-7006.2011.02032.x","volume":"102","author":"E Amodio","year":"2011","unstructured":"Amodio, E. et al. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. Cancer Sci. 102, 1769\u20131773 (2011).","journal-title":"Cancer Sci."},{"key":"27623_CR29","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2006-03-014225","volume":"108","author":"M Lambert","year":"2006","unstructured":"Lambert, M. et al. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108, 3871\u20133880 (2006).","journal-title":"Blood"},{"key":"27623_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/507649","volume":"194","author":"RF Little","year":"2006","unstructured":"Little, R. F. & Yarchoan, R. Poor specific T cell responses to human herpesvirus 8: a key to unleashing Kaposi sarcoma? J. Infect. Dis. 194, 1030\u20131031 (2006).","journal-title":"J. Infect. Dis."},{"key":"27623_CR31","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1086\/315056","volume":"180","author":"HD Strickler","year":"1999","unstructured":"Strickler, H. D. et al. Human herpesvirus 8 cellular immune responses in homosexual men. J. Infect. Dis. 180, 1682\u20131685 (1999).","journal-title":"J. Infect. Dis."},{"key":"27623_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1086\/315777","volume":"182","author":"QJ Wang","year":"2000","unstructured":"Wang, Q. J. et al. CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals. J. Infect. Dis. 182, 928\u201332. (2000).","journal-title":"J. Infect. Dis."},{"key":"27623_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2010.08.019","volume":"305","author":"GS Taylor","year":"2011","unstructured":"Taylor, G. S. & Blackbourn, D. J. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett. 305, 263\u2013278 (2011).","journal-title":"Cancer Lett."},{"key":"27623_CR34","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.4049\/jimmunol.165.4.2077","volume":"165","author":"C Brander","year":"2000","unstructured":"Brander, C. et al. Impaired CTL recognition of cells latently infected with Kaposi\u2019s sarcoma-associated herpes virus. J. Immunol. 165, 2077\u20132083 (2000).","journal-title":"J. Immunol."},{"key":"27623_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1128\/JVI.75.2.891-902.2001","volume":"75","author":"RG Jenner","year":"2001","unstructured":"Jenner, R. G. et al. Kaposi\u2019s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75, 891\u2013902 (2001).","journal-title":"J. Virol."},{"key":"27623_CR36","first-page":"1","volume":"1602","author":"RG Jenner","year":"2002","unstructured":"Jenner, R. G. & Boshoff, C. The molecular pathology of Kaposi\u2019s sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602, 1\u201322 (2002).","journal-title":"Biochim. Biophys. Acta"},{"key":"27623_CR37","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3389\/fimmu.2019.03084","volume":"10","author":"G Broussard","year":"2019","unstructured":"Broussard, G. & Damania, B. KSHV: immune modulation and immunotherapy. Front Immunol. 10, 3084 (2019).","journal-title":"Front Immunol."},{"key":"27623_CR38","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1172\/JCI43755","volume":"121","author":"J Myoung","year":"2011","unstructured":"Myoung, J. & Ganem, D. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J. Clin. Invest. 121, 1130\u20131140 (2011).","journal-title":"J. Clin. Invest."},{"key":"27623_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1086\/432103","volume":"192","author":"T Woodberry","year":"2005","unstructured":"Woodberry, T. et al. Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins. J. Infect. Dis. 192, 622\u2013629 (2005).","journal-title":"J. Infect. Dis."},{"key":"27623_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0166-0934(00)00244-5","volume":"91","author":"CC Yuan","year":"2001","unstructured":"Yuan, C. C., Miley, W. & Waters, D. A quantification of human cells using an ERV-3 real time PCR assay. J. Virol. Methods 91, 109\u2013117 (2001).","journal-title":"J. Virol. Methods"},{"key":"27623_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.10190","volume":"98","author":"S de Sanjose","year":"2002","unstructured":"de Sanjose, S. et al. Prevalence of Kaposi\u2019s sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int. J. Cancer 98, 155\u2013158 (2002).","journal-title":"Int. J. Cancer"},{"key":"27623_CR42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/423326","volume":"190","author":"M Dedicoat","year":"2004","unstructured":"Dedicoat, M. et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J. Infect. Dis. 190, 1068\u201375. (2004).","journal-title":"J. Infect. Dis."},{"key":"27623_CR43","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/infdis\/jiy262","volume":"218","author":"R Newton","year":"2018","unstructured":"Newton, R. et al. Determinants of gammaherpesvirus shedding in saliva among Ugandan children and their mothers. J. Infect. Dis. 218, 892\u2013900 (2018).","journal-title":"J. Infect. Dis."},{"key":"27623_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ije\/dys234","volume":"42","author":"G Asiki","year":"2013","unstructured":"Asiki, G. et al. The General Population Cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. Int J. Epidemiol. 42, 129\u2013141 (2013).","journal-title":"Int J. Epidemiol."},{"key":"27623_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/sextrans-2015-052179","volume":"92","author":"A Kamali","year":"2016","unstructured":"Kamali, A. et al. Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control. Sex. Transm. Infect. 92, 447\u2013454 (2016).","journal-title":"Sex. Transm. Infect."},{"key":"27623_CR46","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/tmi.12464","volume":"20","author":"A Nalwoga","year":"2015","unstructured":"Nalwoga, A. et al. Association between malaria exposure and Kaposi\u2019s sarcoma-associated herpes virus seropositivity in Uganda. Trop. Med. Int. Health 20, 665\u2013672 (2015).","journal-title":"Trop. Med. Int. Health"},{"key":"27623_CR47","doi-asserted-by":"crossref","unstructured":"Newton, R. et al. Kaposi\u2019s sarcoma associated herpesvirus in a rural Ugandan cohort: 1992\u20132008. J. Infect. Dis. 217, 263\u2013269 (2018).","DOI":"10.1093\/infdis\/jix569"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27623-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T19:08:44Z","timestamp":1676056124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27623-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27623"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27623-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7323"}}